This inventor holds 1 USPTO granted patent. Top assignees: The General Hospital Corporation, Ussr Cardiology Research Centre. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1993
Title: Alexander L Klibanov: Innovator in Medical Imaging and Therapeutics
Introduction
Alexander L Klibanov is a prominent inventor based in Moscow, Russia. He is known for his significant contributions to the field of medical imaging and therapeutics. His innovative work has led to the development of a unique patent that enhances the ability to visualize and target specific cells within the body.
Latest Patents
Klibanov holds a patent for "Negatively charged specific affinity reagents." This invention involves an in vivo imaging or therapeutic method that includes administering a specific affinity reagent to a mammal. The reagent consists of a physiologically compatible polymer bonded to specific affinity molecules that can selectively bind to predetermined substances or classes of cells. Additionally, it incorporates reporter groups that provide detectable contrast between the targeted cells and other cells or substances in the mammal.
Career Highlights
Throughout his career, Klibanov has worked with notable organizations, including The General Hospital Corporation and the U.S.S.R. Cardiology Research Centre. His experience in these institutions has allowed him to refine his expertise in medical research and innovation.
Collaborations
Klibanov has collaborated with esteemed colleagues, including Ban A Khaw and Vladimir Torchilin. These partnerships have contributed to the advancement of his research and the successful application of his inventions.
Conclusion
Alexander L Klibanov is a distinguished inventor whose work in medical imaging and therapeutics has made a significant impact in the field. His innovative patent and collaborations highlight his dedication to advancing healthcare technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile